SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001615219-17-000028
Filing Date
2017-04-19
Accepted
2017-04-19 16:16:21
Documents
4
Period of Report
2017-06-01
Effectiveness Date
2017-04-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A flks2017proxy.htm DEF 14A 550808
2 proxycardpage1a03.jpg GRAPHIC 245460
3 proxycardpage2a03.jpg GRAPHIC 200121
4 rhsignature110dpicopy.jpg GRAPHIC 77490
  Complete submission text file 0001615219-17-000028.txt   1271913
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36812 | Film No.: 17770145
SIC: 2834 Pharmaceutical Preparations